Skip to main content
SpringerLink
Log in

V-Go insulin delivery device reduces diabetes drug costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 US dollars

Reference

  • Raval A, et al. Impact of V-Go versus multiple daily injections on glycaemic control, insulin utilisation and diabetes medication costs among individuals with type 2 diabetes. 54th Annual Meeting of the European Association for the Study of Diabetes : abstr. 861, 1 Oct 2018. Available from: URL: http://www.abstractsonline.com/pp8/#!/4612/presentation/5145

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

V-Go insulin delivery device reduces diabetes drug costs. PharmacoEcon Outcomes News 815, 34 (2018). https://doi.org/10.1007/s40274-018-5415-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5415-z

Search

Navigation